Charles Schwab Investment Management Inc Cognition Therapeutics Inc Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 11,965 shares of CGTX stock, worth $19,861. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,965
Previous 11,965
-0.0%
Holding current value
$19,861
Previous $22,000
4.55%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CGTX
# of Institutions
51Shares Held
9.4MCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$3.66 Million0.02% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.9MShares$3.15 Million1.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA922KShares$1.53 Million0.0% of portfolio
-
Awm Investment Company, Inc. New York, NY650KShares$1.08 Million0.18% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$830,0000.01% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $37.7M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...